Robert E. Reiter

22.6k total citations · 9 hit papers
234 papers, 12.0k citations indexed

About

Robert E. Reiter is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Robert E. Reiter has authored 234 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 190 papers in Pulmonary and Respiratory Medicine, 89 papers in Radiology, Nuclear Medicine and Imaging and 33 papers in Cancer Research. Recurrent topics in Robert E. Reiter's work include Prostate Cancer Treatment and Research (157 papers), Prostate Cancer Diagnosis and Treatment (116 papers) and Radiopharmaceutical Chemistry and Applications (48 papers). Robert E. Reiter is often cited by papers focused on Prostate Cancer Treatment and Research (157 papers), Prostate Cancer Diagnosis and Treatment (116 papers) and Radiopharmaceutical Chemistry and Applications (48 papers). Robert E. Reiter collaborates with scholars based in United States, Canada and Germany. Robert E. Reiter's co-authors include Daniel Margolis, Jiaoti Huang, Steven S. Raman, Leonard S. Marks, Owen N. Witte, Joyce M. Yamashiro, Jonathan Said, Charles L. Sawyers, Shyam Natarajan and Lorna Kwan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Robert E. Reiter

224 papers receiving 11.8k citations

Hit Papers

Prostate cancer 1998 2026 2007 2016 2021 1998 1998 2017 2014 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prostate cancer
    2021 663 citations David C. Johnson, Robert E. Reiter et al. profile →
  2. Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer
    1998 556 citations Robert E. Reiter, George Thomas et al. profile →
  3. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression
    1998 526 citations Robert E. Reiter, Jonathan Said et al. profile →
  4. Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT
    2017 386 citations Jérémie Calais, Thomas A. Hope et al. profile →
  5. Multifocality and Prostate Cancer Detection by Multiparametric Magnetic Resonance Imaging: Correlation with Whole-mount Histopathology
    2014 336 citations Lorna Kwan, Leonard S. Marks et al. European Urology profile →
  6. Prostate cancer detection with magnetic resonance‐ultrasound fusion biopsy: The role of systematic and targeted biopsies
    2016 305 citations Shyam Natarajan, Robert E. Reiter et al. Cancer profile →
  7. Value of Targeted Prostate Biopsy Using Magnetic Resonance–Ultrasound Fusion in Men with Prior Negative Biopsy and Elevated Prostate-specific Antigen
    2013 297 citations Geoffrey A. Sonn, Shyam Natarajan et al. European Urology profile →
  8. Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)
    2023 127 citations Jérémie Calais, Robert E. Reiter et al. European Urology profile →
  9. PSMA-PET/CT Findings in Patients With High-Risk Biochemically Recurrent Prostate Cancer With No Metastatic Disease by Conventional Imaging
    2025 19 citations Nicholas G. Nickols, Amar U. Kishan et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robert E. Reiter 7.6k 3.6k 2.8k 2.7k 2.0k 234 12.0k
Jiaoti Huang 8.2k 1.1× 7.3k 2.0× 4.3k 1.5× 1.7k 0.6× 3.8k 1.9× 308 16.4k
Patricia Troncoso 8.0k 1.1× 3.9k 1.1× 4.4k 1.6× 1.3k 0.5× 2.5k 1.2× 256 13.8k
Thorsten Schlomm 5.9k 0.8× 3.7k 1.0× 1.7k 0.6× 967 0.4× 2.6k 1.3× 290 10.0k
Eva Wardelmann 4.1k 0.5× 1.4k 0.4× 2.1k 0.7× 2.7k 1.0× 1.2k 0.6× 292 10.5k
Rajal B. Shah 8.9k 1.2× 7.6k 2.1× 2.5k 0.9× 1.1k 0.4× 3.9k 1.9× 153 14.9k
Sven Perner 6.9k 0.9× 6.5k 1.8× 3.1k 1.1× 1.0k 0.4× 3.8k 1.9× 269 12.9k
Peter E. Huber 3.1k 0.4× 3.0k 0.8× 3.0k 1.1× 2.4k 0.9× 1.5k 0.7× 265 11.5k
Rohit Mehra 8.2k 1.1× 7.2k 2.0× 2.7k 1.0× 920 0.3× 4.1k 2.0× 214 13.8k
Kevin M. Slawin 6.9k 0.9× 2.0k 0.6× 1.9k 0.7× 596 0.2× 1.3k 0.6× 183 10.0k
Lukas Bubendorf 6.4k 0.8× 8.3k 2.3× 6.8k 2.4× 1.7k 0.6× 4.0k 2.0× 326 17.5k

Countries citing papers authored by Robert E. Reiter

Since Specialization
Citations

This map shows the geographic impact of Robert E. Reiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Reiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Reiter more than expected).

Fields of papers citing papers by Robert E. Reiter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Reiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Reiter. The network helps show where Robert E. Reiter may publish in the future.

Co-authorship network of co-authors of Robert E. Reiter

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Reiter. A scholar is included among the top collaborators of Robert E. Reiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Reiter. Robert E. Reiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kim, Daniel H., Ida Sonni, Tristan Grogan, et al.. (2025). Quantitative 3-T Multiparametric MRI Parameters as Predictors of Aggressive Prostate Cancer. Radiology Imaging Cancer. 7(1). e240011–e240011. 1 indexed citations
3.
Yu, Yufei, Robert E. Reiter, & Mo Zhang. (2025). Surgical techniques for enhancing postoperative urinary continence in robot-assisted radical prostatectomy: a comprehensive review. International Journal of Surgery. 111(6). 3931–3941.
4.
Valle, Luca, Holly Wilhalme, Javier Casillas, et al.. (2025). 177Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer: Primary Endpoint Analysis of the Phase II LUNAR Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 123(1). S32–S33.
5.
Weiner, Adam B., Catherine Meyer, Giuseppe Carlucci, et al.. (2024). Clinical Responses to Prostate-specific Membrane Antigen Radioguided Salvage Lymphadenectomy for Prostate Cancer Recurrence: Results from a Prospective Exploratory Trial. European Urology Open Science. 70. 36–42. 2 indexed citations
6.
Rettig, Matthew B., John Shen, Robert E. Reiter, et al.. (2024). Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical Trial. European Urology. 85(6). 517–520. 10 indexed citations
7.
Romero, Tahmineh, Matthew B. Rettig, Michael L. Steinberg, et al.. (2022). Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT. Prostate Cancer and Prostatic Diseases. 26(1). 207–209. 10 indexed citations
8.
Ferdinandus, Justin, Wolfgang P. Fendler, Jérémie Calais, et al.. (2020). Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial. European Urology Open Science. 19. e1215–e1216. 2 indexed citations
9.
Lin, Lin, Naoko Kobayashi, Evelyn A. Kono, et al.. (2020). High-dose per Fraction Radiotherapy Induces Both Antitumor Immunity and Immunosuppressive Responses in Prostate Tumors. Clinical Cancer Research. 27(5). 1505–1515. 57 indexed citations
10.
Tsai, Wen‐Ting K., Kirstin A. Zettlitz, Magnus Dahlbom, Robert E. Reiter, & Anna M. Wu. (2020). Evaluation of [131I]I- and [177Lu]Lu-DTPA-A11 Minibody for Radioimmunotherapy in a Preclinical Model of PSCA-Expressing Prostate Cancer. Molecular Imaging and Biology. 22(5). 1380–1391. 10 indexed citations
11.
Johnson, David C., Lorna Kwan, Sohrab Afshari Mirak, et al.. (2019). Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selection. Cancer. 125(17). 2955–2964. 24 indexed citations
12.
Zhang, Mo, Naoko Kobayashi, Kirstin A. Zettlitz, et al.. (2018). Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models. Clinical Cancer Research. 25(1). 188–200. 26 indexed citations
13.
Priceman, Saul J., Ethan Gerdts, Dileshni Tilakawardane, et al.. (2017). Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer. OncoImmunology. 7(2). e1380764–e1380764. 120 indexed citations
14.
15.
Sonn, Geoffrey A., Ziyue Karen Jiang, Kirstin A. Zettlitz, et al.. (2015). Fluorescent Image–Guided Surgery with an Anti-Prostate Stem Cell Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate Cancer Xenografts in Real Time. Clinical Cancer Research. 22(6). 1403–1412. 41 indexed citations
16.
Knowles, Scott M., Richard Tavaré, Kirstin A. Zettlitz, et al.. (2014). Applications of ImmunoPET: Using 124I-Anti-PSCA A11 Minibody for Imaging Disease Progression and Response to Therapy in Mouse Xenograft Models of Prostate Cancer. Clinical Cancer Research. 20(24). 6367–6378. 25 indexed citations
17.
Hara, Takahito, Hideyo Miyazaki, Aram Lee, Chau P. Tran, & Robert E. Reiter. (2008). Androgen Receptor and Invasion in Prostate Cancer. Cancer Research. 68(4). 1128–1135. 98 indexed citations
18.
Thomas, George, Steve Horvath, Bradley L. Smith, et al.. (2004). Antibody-Based Profiling of the Phosphoinositide 3-Kinase Pathway in Clinical Prostate Cancer. Clinical Cancer Research. 10(24). 8351–8356. 54 indexed citations
19.
Jalkut, Mark & Robert E. Reiter. (2002). Role of prostate stem cell antigen in prostate cancer research. Current Opinion in Urology. 12(5). 401–406. 23 indexed citations
20.
Reiter, Robert E., et al.. (1993). Chromosome 17p deletions and p53 mutations in renal cell carcinoma.. PubMed. 53(13). 3092–7. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiaoti Huang Breakdown of academic impact, for papers by Patricia Troncoso Breakdown of academic impact, for papers by Thorsten Schlomm Breakdown of academic impact, for papers by Eva Wardelmann Breakdown of academic impact, for papers by Rajal B. Shah Breakdown of academic impact, for papers by Sven Perner Breakdown of academic impact, for papers by Peter E. Huber Breakdown of academic impact, for papers by Rohit Mehra Breakdown of academic impact, for papers by Kevin M. Slawin Breakdown of academic impact, for papers by Lukas Bubendorf
Rankless by CCL
2026